Bionics-AIChief Executive Officer
Jan. 2025Boston, Massachusetts, United States• Spearheaded the development of an AI-native platform for discovering small molecules targeting diseases like cancer and diabetes. • Successfully launched B7-H3X1, an innovative immunomodulatory compound, advancing our preclinical pipeline. • Cultivated partnerships for global scientific collaborations while raising funding to support our mission in biotech innovation.